Metraipolis › archive › dc_eb89db07ccac

Lung cancer vaccines to enhance immune checkpoint inhibitor therapy: evidence and future perspectives — Europe PMC PMID:41634728

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41634728
DOI: 10.1186/s13045-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-06T04:05:47.451Z
SHA-256 of the archived text: 4425d0def08ee730953ac1a2182be70aa711438e4a1dc99559d46fdcadc744ca
Stable URL of this page: https://metraipolis.com/documento/dc_eb89db07ccac

How to cite

Lung cancer vaccines to enhance immune checkpoint inhibitor therapy: evidence and future perspectives — Europe PMC PMID:41634728 — Europe PMC (en), https://europepmc.org/article/MED/41634728 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb89db07ccac (Metraipolis archive dc_eb89db07ccac, sha256 4425d0def08ee730953ac1a2182be70aa711438e4a1dc99559d46fdcadc744ca)

BibTeX

@misc{dceb89db07ccac,
  title = {Lung cancer vaccines to enhance immune checkpoint inhibitor therapy: evidence and future perspectives — Europe PMC PMID:41634728},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41634728},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb89db07ccac; sha256 4425d0def08ee730953ac1a2182be70aa711438e4a1dc99559d46fdcadc744ca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41634728. Agents can read the archived copy with the MCP tool read_document.